Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
FMBH
|
Zachary Horn
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 347 Added 0.0% |
$12,072
$34.79 p/Share
|
Apr 02
2025 |
|
FMBH
|
James Kyle Mc Curry
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 362 Added 0.0% |
$12,593
$34.79 p/Share
|
Apr 02
2025 |
|
FTCI
|
Ahmad R Chatila |
BUY
Open market or private purchase
|
Direct | 16,740 Added 0.84% |
$49,048
$2.93 p/Share
|
Apr 02
2025 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,403 Added 0.0% |
$16,457
$11.73 p/Share
|
Apr 02
2025 |
|
W
|
Kate Gulliver
CFO and Chief Admin Officer |
SELL
Open market or private sale
|
Direct | 19,296 Reduced 11.78% |
$614,384
$31.84 p/Share
|
Apr 02
2025 |
|
W
|
Jon Blotner
Pres., Commercial & Operations |
SELL
Open market or private sale
|
Direct | 19,257 Reduced 19.74% |
$612,950
$31.83 p/Share
|
Apr 02
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 45,440 Reduced 0.48% |
$570,726
$12.56 p/Share
|
Apr 02
2025 |
|
W
|
Fiona Tan
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 23,835 Reduced 17.66% |
$763,435
$32.03 p/Share
|
Apr 02
2025 |
|
STAA
|
Broadwood Partners, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Apr 02
2025 |
|
STAA
|
Broadwood Partners, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 31,780 Added 0.25% |
$553,925
$17.43 p/Share
|
Apr 02
2025 |
|
ITCI
|
Eduardo Rene Salas |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,567 Reduced 100.0% |
$206,844
$132.0 p/Share
|
Apr 02
2025 |
|
STGW
|
Mark Jeffery Penn
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect | 151,648,741 Added 0.0% |
-
|
Apr 02
2025 |
|
ZYME
|
Eco R1 Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 74,360 Added 0.0% |
$881,166
$11.85 p/Share
|
Apr 02
2025 |
|
CVNA
|
Benjamin E. Huston
Chief Operating Officer |
BUY
Conversion of derivative security
|
Direct | 50,000 Added 22.34% |
-
|
Apr 02
2025 |
|
SDHI
|
Brian D Finn
Director |
BUY
Open market or private purchase
|
Indirect | 338,000 Added 0.0% |
-
|
Apr 02
2025 |
|
FGBI
|
Edgar R. Smith Iii
Director |
BUY
Open market or private purchase
|
Indirect | 98,460 Added 0.0% |
$833,956
$8.47 p/Share
|
Apr 02
2025 |
|
SDHI
|
Siddhi Sponsor LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 338,000 Added 4.46% |
-
|
Apr 02
2025 |
|
ADVM
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect | 15,209 Added 0.0% |
$61,444
$4.04 p/Share
|
Apr 02
2025 |
|
MRMD
|
Jon R Levine
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,984 Reduced 0.04% |
$798
$0.1 p/Share
|
Apr 02
2025 |
|
MRMD
|
Jon R Levine
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 23,041 Added 0.11% |
-
|
Apr 02
2025 |
|
MRMD
|
Timothy Shaw
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 19,969 Added 0.23% |
-
|
Apr 02
2025 |
|
MRMD
|
Timothy Shaw
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,920 Reduced 0.08% |
$692
$0.1 p/Share
|
Apr 02
2025 |
|
PPBI
|
Michael S Karr
SEVP & Chief Risk Officer |
SELL
Bona fide gift
|
Direct | 1,384 Reduced 4.32% |
-
|
Apr 02
2025 |
|
PPBI
|
Michael S Karr
SEVP & Chief Risk Officer |
BUY
Bona fide gift
|
Indirect | 1,384 Added 0.0% |
-
|
Apr 02
2025 |
|
PPBI
|
Tom Rice
SEVP/ Chief Innovation Officer |
SELL
Bona fide gift
|
Direct | 1,898 Reduced 5.83% |
-
|
Apr 02
2025 |
|
PPBI
|
Tom Rice
SEVP/ Chief Innovation Officer |
BUY
Bona fide gift
|
Indirect | 1,898 Added 0.0% |
-
|
Apr 02
2025 |
|
JLS
|
Aashh Parekh |
BUY
Open market or private purchase
|
Direct | 100 Added 2.17% |
$1,825
$18.25 p/Share
|
Apr 02
2025 |
|
AVMR
|
Barry F Cohen
COO - Americas |
BUY
Open market or private purchase
|
Direct | 420 Added 0.0% |
$3,863
$9.2 p/Share
|
Apr 02
2025 |
|
ITCI
|
Michael Halstead
President |
SELL
Sale (or disposition) back to the issuer
|
Direct | 21,307 Reduced 100.0% |
$2,812,524
$132.0 p/Share
|
Apr 02
2025 |
|
VEEV
|
Jonathan Faddis
SVP, Gen. Counsel, Secretary |
SELL
Open market or private sale
|
Direct | 787 Reduced 8.32% |
$178,019
$226.2 p/Share
|
Apr 02
2025 |
|
ITCI
|
Rory B Riggs |
SELL
Sale (or disposition) back to the issuer
|
Direct | 131,512 Reduced 100.0% |
$17,359,584
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Mark Neumann
EVP, Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 52,811 Reduced 100.0% |
$6,971,052
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Robert L Van Nostrand |
SELL
Sale (or disposition) back to the issuer
|
Direct | 11,340 Reduced 100.0% |
$1,496,880
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Suresh K. Durgam
EVP, Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 42,913 Reduced 100.0% |
$5,664,516
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Sharon Mates
Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 945,235 Reduced 100.0% |
$124,771,020
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Sharon Mates
Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 190,000 Reduced 0.0% |
$25,080,000
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Joel S Marcus |
SELL
Sale (or disposition) back to the issuer
|
Direct | 48,238 Reduced 100.0% |
$6,367,416
$132.0 p/Share
|
Apr 02
2025 |
|
ITCI
|
Joel S Marcus |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 10,000 Reduced 0.0% |
$1,320,000
$132.0 p/Share
|
Apr 02
2025 |
|
SHIM
|
Mitchell B. Goldsteen |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$3,520
$1.76 p/Share
|
Apr 02
2025 |
|
UAVS
|
Adrienne Anderson
Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 33.33% |
-
|
Apr 02
2025 |
|
LXP
|
Arun Gupta
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 4.58% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Lawrence L Gray
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 50.0% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Nancy Elizabeth Noe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 50.0% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Claire A Koeneman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 3.1% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Derrick L Johnson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 8.84% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Jamie Handwerker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 3.26% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
LXP
|
Howard Stewart Roth
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,790 Added 3.75% |
$32,480
$8.57 p/Share
|
Apr 02
2025 |
|
DCGO
|
Stephen Sugrue
Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,614 Reduced 1.59% |
$15,045
$2.68 p/Share
|
Apr 02
2025 |
|
DCGO
|
Lee Bienstock
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 18,598 Reduced 0.94% |
$49,842
$2.68 p/Share
|
Apr 02
2025 |
|
DCGO
|
Norman Rosenberg
CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,004 Reduced 0.93% |
$21,450
$2.68 p/Share
|
Apr 02
2025 |